WeRide Inc. — Capital/Financing Update 2026

Feb 6, 2026

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Field: Rule-Page

Field: /Rule-Page

FORM 6-K

Field: Rule-Page

Field: /Rule-Page

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of February 2026

Commission File Number: 001-42213

Field: Rule-Page

Field: /Rule-Page

WeRide Inc.

Field: Rule-Page

Field: /Rule-Page

21st Floor, Tower A, Guanzhou Life Science Innovation Center

No. 51, Luoxuan Road, Guangzhou International Biotech Island

Guangzhou 510005

People’s Republic of China

(Address of principal executive offices)

Field: Rule-Page

Field: /Rule-Page

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

EXPLANATORY NOTE

We submitted a monthly return form dated February 5, 2026 in relation to the movements in our authorized share capital and issued shares in January 2026 to The Stock Exchange of Hong Kong Limited. For details, please refer to the exhibit to this current report on Form 6-K.

Field: Page; Sequence: 2

Field: /Page

EXHIBIT INDEX

Exhibit No.	Description
99.1	Monthly Return for Equity Issuer on Movements in Securities

Field: Page; Sequence: 3

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

WeRide Inc.
By:	/s/ Jennifer Li
Name:	Jennifer Li
Title:	Chief Financial Officer

Date: February 6, 2026

Field: Page; Sequence: 4; Options: Last

Field: /Page